Is PlayAGS (AGS) Outperforming Other Consumer Discretionary Stocks This Year? — Positive
AGS Zacks Investment Research — March 27, 2025Here is how PlayAGS (AGS) and Naspers Ltd. (NPSNY) have performed compared to their sector so far this year.

Should Value Investors Buy Cardinal Health (CAH) Stock? — Positive
CAH Zacks Investment Research — March 27, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Ultrapar Participacoes (UGP) Right Now? — Positive
UGP Zacks Investment Research — March 27, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Brinker International (EAT) Stock Outpacing Its Retail-Wholesale Peers This Year? — Positive
EAT Zacks Investment Research — March 27, 2025Here is how Brinker International (EAT) and Farmer Brothers (FARM) have performed compared to their sector so far this year.

Should Value Investors Buy Newmark Group (NMRK) Stock? — Positive
NMRK Zacks Investment Research — March 27, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? — Negative
AUNA Zacks Investment Research — March 27, 2025Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.

Should Value Investors Buy Criteo (CRTO) Stock? — Positive
CRTO Zacks Investment Research — March 27, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Auto-Tires-Trucks Stocks Lagging Luminar Technologies (LAZR) This Year? — Negative
LAZR Zacks Investment Research — March 27, 2025Here is how Luminar Technologies, Inc. (LAZR) and XPeng Inc. Sponsored ADR (XPEV) have performed compared to their sector so far this year.

Are Investors Undervaluing PlayAGS (AGS) Right Now? — Positive
AGS Zacks Investment Research — March 27, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Evaporative Coolers Market Growth Trends and Forecast Report 2025-2033: Includes Financials & Strategies of Honeywell International, Munters Group, Phoenix Manufacturing & More — Neutral
HON GlobeNewsWire — March 27, 2025Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Evaporative Cooler Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering. The Evaporative Cooling market is expected to reach US$ 12.06 billion by 2033 from US$ 6.95 billion in 2024, with a CAGR of 6.32% from 2025 to 2033. Key drivers propelling the rise of the evaporative cooling market share include the growing industrial sector's usage of evaporative cooling, the growing need for affordable, sustainable, and energy-efficient solutions, and a number of initiatives by regulatory agencies.

SAN CARLOS, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, today confirmed receipt of a notice from Findell Capital Management LLC (“Findell”) nominating two directors to stand for election to the Oportun Board of Directors (the “Board”) at the Company's 2025 Annual Meeting of Shareholders. The Board issued the following statement in response:

PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call Transcript — Neutral
PDSB Seeking Alpha — March 27, 2025PDS Biotechnology Corporation (NASDAQ:PDSB ) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company Participants Tom Johnson - LifeSci Advisors Frank Bedu-Addo - CEO Kirk Shepard - Chief Medical Officer Lars Boesgaard - CFO Conference Call Participants Joseph Pantginis - H.C. Wainwright Mayank Mamtani - B.

Is Superior Group (SGC) a Buy as Wall Street Analysts Look Optimistic? — Positive
SGC Zacks Investment Research — March 27, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Affirm Holdings (AFRM) Is Considered a Good Investment by Brokers: Is That True? — Positive
AFRM Zacks Investment Research — March 27, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet — Negative
AZN Zacks Investment Research — March 27, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Wall Street Analysts See AST SpaceMobile (ASTS) as a Buy: Should You Invest? — Negative
ASTS Zacks Investment Research — March 27, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

JEF Q1 Earnings Lag Estimates on Weak IB & Capital Markets, Stock Down — Negative
JEF Zacks Investment Research — March 27, 2025Jefferies' first-quarter fiscal 2025 results miss estimates due to weak equity underwriting and fixed income performance, partially offset by lower expenses.

Down -29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in MBIA (MBI) — Positive
MBI Zacks Investment Research — March 27, 2025MBIA (MBI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -26.43% in 4 Weeks, Here's Why eHealth (EHTH) Looks Ripe for a Turnaround — Positive
EHTH Zacks Investment Research — March 27, 2025eHealth (EHTH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -34.51% in 4 Weeks, Here's Why You Should You Buy the Dip in Butterfly Network (BFLY) — Positive
BFLY Zacks Investment Research — March 27, 2025Butterfly Network (BFLY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
